Macrophage Membrane-Derived Biomimetic Nanoparticles for Treatment of Cytokine Release Syndrome
Journal of Biomedical Nanotechnology · 01.04.2022 · 18 (4) · 1064-1074
DOI: 10.1166/jbn.2022.3324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Nanotechnology, erschienen am 01.04.2022. Verfasst von Huirong Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Cytokine release syndrome (CRS) is a severe complication of infectious diseases like Coronavirus disease 2019 (COVID-19) that cause serious damage to public health. Currently, supportive therapy is still the main therapeutic strategy exists for CRS treatment. Here, we show the potential of macrophage membrane-derived biomimetic nanoparticles for CRS treatment. By fusing macrophage membrane on the surface of the PLGA nano core, we constructed biomimetic nanoparticles that inherited the membrane receptors from the “parental” macrophages, enabling the neutralization of CRS-related cytokines. We compared three types of macrophage membranes to screen out more effective biomimetic nanoparticles for CRS treatment. Our results show that M0 macrophage membrane-derived biomimetic nanoparticles could neutralize pro-inflammatory cytokines involved in CRS to the greatest extent and reduce organ damage in a mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China.
- Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
- Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Zitieren
APA
Jiang, H., Tai, Z., Pan, H., Cui, Z., Chai, R., Zhu, C., Tian, J., Bao, L., Zhu, Q., & Chen, Z. (2022). Macrophage Membrane-Derived Biomimetic Nanoparticles for Treatment of Cytokine Release Syndrome. Journal of Biomedical Nanotechnology, 18(4), 1064-1074. https://doi.org/10.1166/jbn.2022.3324
Vancouver
Jiang H, Tai Z, Pan H, Cui Z, Chai R, Zhu C, et al. Macrophage Membrane-Derived Biomimetic Nanoparticles for Treatment of Cytokine Release Syndrome. Journal of Biomedical Nanotechnology. 2022;18(4):1064-1074. doi:10.1166/jbn.2022.3324
BibTeX
@article{Jiang2022,
author = {Jiang, Huirong and Tai, Zongguang and Pan, Huijun and Cui, Zhen and Chai, Rongrong and Zhu, Congcong and Tian, Jing and Bao, Leilei and Zhu, Quangang and Chen, Zhongjian},
title = {Macrophage Membrane-Derived Biomimetic Nanoparticles for Treatment of Cytokine Release Syndrome},
journal = {Journal of Biomedical Nanotechnology},
year = {2022},
volume = {18},
number = {4},
pages = {1064--1074},
doi = {10.1166/jbn.2022.3324}
}
EUVIMED